Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 4,834,653 | 4,540,132 | -294,521 | $118.45M | $112.60M | 48.91% | -$5.85M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $76.36M | $66.15M | 28.73% | -$10.22M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $30.18M | $27.75M | 12.05% | -$2.43M |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $9.72M | $11.33M | 4.92% | +$1.61M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $7.95M | $7.29M | 3.17% | -$659.0K |
| Singular Genomics Systems, Inc. | 126,630 | 126,630 | 0 | $1.98M | $2.46M | 1.07% | +$476.1K |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $14.30M | $1.10M | 0.48% | -$13.20M |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $1.48M | $981.1K | 0.43% | -$496.0K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 1,444,296 | 9,393,561 | +7,949,265 | $134.8K | $563.6K | 0.24% | +$428.9K |